MX351941B - Formas sólidas de moduladores selectivos de receptor de andrógenos. - Google Patents

Formas sólidas de moduladores selectivos de receptor de andrógenos.

Info

Publication number
MX351941B
MX351941B MX2016010097A MX2016010097A MX351941B MX 351941 B MX351941 B MX 351941B MX 2016010097 A MX2016010097 A MX 2016010097A MX 2016010097 A MX2016010097 A MX 2016010097A MX 351941 B MX351941 B MX 351941B
Authority
MX
Mexico
Prior art keywords
solid forms
androgen receptor
receptor modulators
selective androgen
selective
Prior art date
Application number
MX2016010097A
Other languages
English (en)
Inventor
T Dalton James
Ahn Tai
Dickason Dave
Soo Hong Seoung-
G Bird Thomas
Original Assignee
Gtx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gtx Inc filed Critical Gtx Inc
Publication of MX351941B publication Critical patent/MX351941B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/60—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Abstract

La presente invención se refiere a formas sólidas de (S)-N-(4-ciano-3-(trifluorometil)fenil)-3-(4-cianofenoxi)-2-hidro xi-2-metilpropanamida y los procesos para producir las mismas.
MX2016010097A 2007-09-11 2008-09-11 Formas sólidas de moduladores selectivos de receptor de andrógenos. MX351941B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96001207P 2007-09-11 2007-09-11
PCT/US2008/076066 WO2009036206A1 (en) 2007-09-11 2008-09-11 Solid forms of selective androgen receptor modulators

Publications (1)

Publication Number Publication Date
MX351941B true MX351941B (es) 2017-11-03

Family

ID=40452483

Family Applications (6)

Application Number Title Priority Date Filing Date
MX2010002784A MX2010002784A (es) 2007-09-11 2008-09-11 Formas solidas de moduladores selectivos del receptor de androgenos.
MX2016010097A MX351941B (es) 2007-09-11 2008-09-11 Formas sólidas de moduladores selectivos de receptor de andrógenos.
MX2017007289A MX360801B (es) 2007-09-11 2008-09-11 Formas solidas de moduladores selectivos de receptor de androgenos.
MX2012013653A MX336760B (es) 2007-09-11 2008-09-11 Formas solidas de moduladores selectivos de receptor de androgenos.
MX2012013650A MX341090B (es) 2007-09-11 2008-09-11 Formas solidas de moduladores selectivos de receptor de androgenos.
MX2018014065A MX2018014065A (es) 2007-09-11 2010-03-11 Formas solidas de moduladores selectivos de receptor de androgenos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2010002784A MX2010002784A (es) 2007-09-11 2008-09-11 Formas solidas de moduladores selectivos del receptor de androgenos.

Family Applications After (4)

Application Number Title Priority Date Filing Date
MX2017007289A MX360801B (es) 2007-09-11 2008-09-11 Formas solidas de moduladores selectivos de receptor de androgenos.
MX2012013653A MX336760B (es) 2007-09-11 2008-09-11 Formas solidas de moduladores selectivos de receptor de androgenos.
MX2012013650A MX341090B (es) 2007-09-11 2008-09-11 Formas solidas de moduladores selectivos de receptor de androgenos.
MX2018014065A MX2018014065A (es) 2007-09-11 2010-03-11 Formas solidas de moduladores selectivos de receptor de androgenos.

Country Status (20)

Country Link
US (1) US7977386B2 (es)
EP (2) EP2871177B1 (es)
JP (3) JP5452492B2 (es)
KR (3) KR101580905B1 (es)
CN (3) CN101855198B (es)
AU (1) AU2008298901C1 (es)
CA (3) CA2709118C (es)
CY (1) CY1120107T1 (es)
DK (1) DK2205552T3 (es)
EA (1) EA018611B1 (es)
ES (1) ES2665007T3 (es)
HR (1) HRP20180500T1 (es)
HU (1) HUE036762T2 (es)
IL (2) IL204352A (es)
LT (1) LT2205552T (es)
MX (6) MX2010002784A (es)
NO (1) NO2205552T3 (es)
PL (1) PL2205552T3 (es)
PT (1) PT2205552T (es)
WO (1) WO2009036206A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7855229B2 (en) * 2000-08-24 2010-12-21 University Of Tennessee Research Foundation Treating wasting disorders with selective androgen receptor modulators
US7919647B2 (en) 2000-08-24 2011-04-05 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US8853266B2 (en) * 2001-12-06 2014-10-07 University Of Tennessee Research Foundation Selective androgen receptor modulators for treating diabetes
US20070161608A1 (en) * 2001-12-06 2007-07-12 Dalton James T Selective androgen receptor modulators for treating muscle wasting
US9884038B2 (en) 2004-06-07 2018-02-06 University Of Tennessee Research Foundation Selective androgen receptor modulator and methods of use thereof
US9889110B2 (en) 2004-06-07 2018-02-13 University Of Tennessee Research Foundation Selective androgen receptor modulator for treating hormone-related conditions
US20110237664A1 (en) * 2004-06-07 2011-09-29 Dalton James T Selective androgen receptor modulators for treating diabetes
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
US9730908B2 (en) 2006-08-24 2017-08-15 University Of Tennessee Research Foundation SARMs and method of use thereof
US10010521B2 (en) 2006-08-24 2018-07-03 University Of Tennessee Research Foundation SARMs and method of use thereof
JP5452492B2 (ja) * 2007-09-11 2014-03-26 ジーティーエックス・インコーポレイテッド 選択的アンドロゲン受容体調節因子の固体形態
US7968603B2 (en) 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators
EP2523556A4 (en) * 2010-01-11 2013-08-28 Gtx Inc METHOD FOR TREATING MIBROMED DYNAMIC FUNCTION
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
RU2717835C2 (ru) 2012-07-13 2020-03-26 Джи Ти Икс, ИНК. Способ лечения андроген-рецептор(ar)-положительных форм рака молочной железы с использованием селективных модуляторов андрогенных рецепторов (sarm)
US10314807B2 (en) 2012-07-13 2019-06-11 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US10987334B2 (en) 2012-07-13 2021-04-27 University Of Tennessee Research Foundation Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
US9969683B2 (en) 2012-07-13 2018-05-15 Gtx, Inc. Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
CN110563607B (zh) * 2019-10-25 2022-07-08 许昌远志生物科技有限公司 一种mk-2866的精制方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050038110A1 (en) 2000-08-24 2005-02-17 Steiner Mitchell S. Selective androgen receptor modulators and methods of use thereof
US7919647B2 (en) 2000-08-24 2011-04-05 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US7645898B2 (en) 2000-08-24 2010-01-12 University Of Tennessee Research Foundation Selective androgen receptor modulators and method of use thereof
US7622503B2 (en) 2000-08-24 2009-11-24 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US20070173546A1 (en) * 2000-08-24 2007-07-26 Dalton James T Selective androgen receptor modulators and method of use thereof
US7855229B2 (en) 2000-08-24 2010-12-21 University Of Tennessee Research Foundation Treating wasting disorders with selective androgen receptor modulators
DE60124322T2 (de) * 2000-08-24 2007-05-31 University Of Tennessee Research Foundation, Knoxville Selektive modulatoren des androgenrezeptors und methoden zu deren verwendung
US7026500B2 (en) * 2000-08-24 2006-04-11 University Of Tennessee Research Foundation Halogenated selective androgen receptor modulators and methods of use thereof
IL155041A0 (en) * 2000-09-21 2003-10-31 Bristol Myers Squibb Co Process for the preparation of n-(substituted phenyl)-3-alkyl-, aryl-and heteroarylsulfonyl-2-hydroxy-2-alkyl-and haloalkylpropanamide compounds
DK1463497T3 (da) * 2001-12-06 2012-01-30 Gtx Inc Behandling af muskelsvind med selektive androgenreceptormodulatorer
US20070161608A1 (en) * 2001-12-06 2007-07-12 Dalton James T Selective androgen receptor modulators for treating muscle wasting
US8853266B2 (en) 2001-12-06 2014-10-07 University Of Tennessee Research Foundation Selective androgen receptor modulators for treating diabetes
US7705182B2 (en) * 2002-02-28 2010-04-27 University Of Tennessee Research Foundation Multi-substituted selective androgen receptor modulators and methods of use thereof
CA2502209A1 (en) * 2002-10-15 2004-04-29 University Of Tennessee Research Foundation Methylene-bridged selective androgen receptor modulators and methods of use thereof
US7968721B2 (en) * 2003-01-13 2011-06-28 University Of Tennessee Research Foundation Large-scale synthesis of selective androgen receptor modulators
EP2476415A3 (en) 2003-10-14 2012-08-29 University of Tennessee Research Foundation Treating bone-related disorders with selective androgen receptor modulators
EP1931199A4 (en) 2005-08-31 2009-07-29 Univ Tennessee Res Foundation TREATMENT OF RENAL DISEASE, BURNS, INJURIES OR SPINAL CORD INJURY USING ANDROGEN RECEPTOR SELECTIVE MODULATORS
TW200730505A (en) 2005-12-07 2007-08-16 Merck & Co Inc Polymorphs of an androgen receptor modulator
CN1825959A (zh) * 2006-03-02 2006-08-30 复旦大学 一种基于自适应多步搜索的图像跟踪算法
JP5452492B2 (ja) * 2007-09-11 2014-03-26 ジーティーエックス・インコーポレイテッド 選択的アンドロゲン受容体調節因子の固体形態
US7968603B2 (en) * 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators

Also Published As

Publication number Publication date
US20090088480A1 (en) 2009-04-02
EP2205552A1 (en) 2010-07-14
JP2014133744A (ja) 2014-07-24
EA201070350A1 (ru) 2010-12-30
MX2018014065A (es) 2020-09-02
PL2205552T3 (pl) 2018-07-31
NO2205552T3 (es) 2018-07-28
US7977386B2 (en) 2011-07-12
CA2709118C (en) 2018-03-13
AU2008298901B2 (en) 2013-05-09
HRP20180500T1 (hr) 2018-06-01
KR101691877B1 (ko) 2017-01-02
WO2009036206A1 (en) 2009-03-19
CN101855198B (zh) 2013-07-10
CA2709118A1 (en) 2009-03-19
EP2871177A1 (en) 2015-05-13
KR20170001736A (ko) 2017-01-04
MX336760B (es) 2016-01-29
JP5599380B2 (ja) 2014-10-01
EP2205552B1 (en) 2018-02-28
CN101855198A (zh) 2010-10-06
EA018611B1 (ru) 2013-09-30
EP2871177B1 (en) 2019-07-17
PT2205552T (pt) 2018-04-24
MX341090B (es) 2016-08-08
KR20160003335A (ko) 2016-01-08
KR20100090239A (ko) 2010-08-13
IL251483A0 (en) 2017-05-29
IL204352A (en) 2013-10-31
JP5727636B2 (ja) 2015-06-03
CA2886498C (en) 2017-09-26
CN103073450A (zh) 2013-05-01
JP2010539181A (ja) 2010-12-16
DK2205552T3 (en) 2018-04-16
MX2010002784A (es) 2011-06-01
HUE036762T2 (hu) 2018-07-30
AU2008298901A1 (en) 2009-03-19
LT2205552T (lt) 2018-04-10
CA2886501A1 (en) 2009-03-19
CA2886498A1 (en) 2009-03-19
JP5452492B2 (ja) 2014-03-26
CN103553966A (zh) 2014-02-05
ES2665007T3 (es) 2018-04-24
JP2012067118A (ja) 2012-04-05
CN103553966B (zh) 2016-09-07
CA2886501C (en) 2018-03-27
CY1120107T1 (el) 2018-12-12
CN103073450B (zh) 2014-12-03
AU2008298901C1 (en) 2013-10-03
KR101580905B1 (ko) 2015-12-29
EP2205552A4 (en) 2012-04-18
MX360801B (es) 2018-11-16

Similar Documents

Publication Publication Date Title
MX2018014065A (es) Formas solidas de moduladores selectivos de receptor de androgenos.
GEP20125586B (en) Novel method for synthesis of (7-methoxy-l-naphthyl)-acetonitrile and application thereof in synthesis of agomelatine
MY156511A (en) Compositions and devices
HK1134280A1 (es)
EP2467359A4 (en) (BIS-) UREA- AND (BIS-) THIOMINE COMPOUNDS AS EPIGENE MODULATORS OF THE LYSINE-SPECIFIC DEMETHYLASE 1 AND METHODS OF DISEASE TREATMENT THEREWITH
MX2007005936A (es) Una sintesis asimetrica del acido (s)-(+)-3-(aminometil)-5- metilhexanoico.
SI1797037T1 (sl) Postopek priprave 4-(4-((((4-kloro-3-(trifluorometil)fenil)amino)karbonil)amino) fenioksi)N-metilpiridin-2-karboksamida
UA99936C2 (en) Biaryl substituted azabicyclic alkane derivatives
WO2008042571A3 (en) Substituted indole compounds
EP2323667A4 (en) MODULATION OF TRANSTHYRETIN EXPRESSION BY TREATMENT OF CNS DISEASES
EP2379493A4 (en) PROCESS FOR THE PREPARATION OF ASYMMETRIC BIS (THIOSEMICARBAZONES)
MX2010005530A (es) Activadores de receptor de vitamina d nuevos y metodos de elaboracion de los mismos.
EA200802072A1 (ru) Ликопин для лечения нарушения обмена веществ
DK2166004T3 (da) Ny fremgangsmåde til adskillelse af enantiomerer af (3,4-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl)nitril og anvendelse heraf til syntese af ivabradin
EA200601267A1 (ru) Модуляторы рецепторов андрогена
HK1147267A1 (en) Manufacture, compositions and uses of coagulationfactor viia modulator
MY143269A (en) Use of agomelatine in obtaining medicaments intended for the treatment of generalized anxiety disorder
PL1896425T3 (pl) Sposób wytwarzania 5-(metylo-1H-1-ilo)-3-trifluorometylo)-benzenoaminy
HRP20130586T1 (en) Additives for altering the hardening rate of chemically bonded silico-phosphate cements and method therefor
MY151100A (en) Salts of n-[6-cis-2, 6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4?-(trifluoromethoxy)[1,1?-biphenyl]-3-carboxamide
EP1951291A4 (en) METHOD FOR REGULATING RENALASE (MONOAMINOXIDASE C)
WO2010148177A3 (en) Compounds, compositions, methods of synthesis, and methods of treatment
HK1131609A1 (en) Acetamide and carboxamide derivatives of azaadamantane and methods of use thereof
GEP20094746B (en) Use of agomelatine to obtain medication aimed at treating smith-magenis syndrome
ATE417816T1 (de) Anilinohexafluoroisopropanol verbindungen